HUP0102894A2 - Helyettesített triazolopiridazin-származék, valamint ilyen vegyületet tartalmazó gyógyászati készítmények - Google Patents
Helyettesített triazolopiridazin-származék, valamint ilyen vegyületet tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0102894A2 HUP0102894A2 HU0102894A HUP0102894A HUP0102894A2 HU P0102894 A2 HUP0102894 A2 HU P0102894A2 HU 0102894 A HU0102894 A HU 0102894A HU P0102894 A HUP0102894 A HU P0102894A HU P0102894 A2 HUP0102894 A2 HU P0102894A2
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- reacted
- group
- triazolo
- Prior art date
Links
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 10
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 abstract 2
- 102000027484 GABAA receptors Human genes 0.000 abstract 1
- 108091008681 GABAA receptors Proteins 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 abstract 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract 1
- 229910001961 silver nitrate Inorganic materials 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány egy szubsztituált triazolopiridazin-származékra, ezt avegyületet tartalmazó gyógyászati készítményekre, illetve ennek avegyületnek gyógyászati készítmények előállításához való alkalmazásáravonatkozik. Közelebbről a találmány az (I) képletű 7-(1,1-dimetiletil)-6-(2-etil-2H-1,2,4-triazol-3-ilmetoxi)-3-(2-fluorfenil)-1,2,4-triazolo[4,3-b]piridazinra vonatkozik, amely egy GABAA receptorligandum és így felhasználható különböző káros mentális állapotokkezelésére. A találmány értelmében az (I) képletű vegyületet úgyállítják elő, hogy a) valamely (III) általános képletű vegyületet - aképletben L1 jelentése kilépő csoport - a (IV) képletű vegyülettelreagáltatják, vagy b) a (XI) képletű vegyületet vagy 1,2,4-triazolo[4,3-b]piridazin-6-on tautomerjét valamely (XII) általánosképletű vegyülettel - a képletben L3 jelentése kilépő csoport -reagáltatják, vagy c) trimetilecetsavat a (XIII) képletű vegyülettelreagáltatják ezüstnitrát és ammóniumperszulfát jelenlétében, vagy d)valamely (XIV) általános képletű vegyületet - a képletben L4 jelentésekilépő csoport - valamely (XV) általános képletű vegyülettel - aképletben M jelentése -B(OH)2 vagy Sn(Alk)3 általános képletű csoport,és az utóbbiban Alk jelentése 1-6 szénatomot tartalmazó alkilcsoport,jellegzetesen n=butilcsoport - reagáltatnak egy átmenetifémkatalizátor jelenlétében. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9813576.7A GB9813576D0 (en) | 1998-06-24 | 1998-06-24 | Therapeutic agents |
| PCT/GB1999/001897 WO1999067245A1 (en) | 1998-06-24 | 1999-06-15 | A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102894A2 true HUP0102894A2 (hu) | 2001-11-28 |
| HUP0102894A3 HUP0102894A3 (en) | 2003-03-28 |
Family
ID=10834265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102894A HUP0102894A3 (en) | 1998-06-24 | 1999-06-15 | A substituted triazolo-pyridazine derivative, pharmaceutical compositions containing them |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6630471B1 (hu) |
| EP (1) | EP1090004B1 (hu) |
| JP (1) | JP4749545B2 (hu) |
| KR (1) | KR100604108B1 (hu) |
| CN (1) | CN1138779C (hu) |
| AR (1) | AR018925A1 (hu) |
| AT (1) | ATE239730T1 (hu) |
| AU (1) | AU757315B2 (hu) |
| BG (1) | BG64989B1 (hu) |
| BR (1) | BR9911563A (hu) |
| CA (1) | CA2335328C (hu) |
| CO (1) | CO5031239A1 (hu) |
| CZ (1) | CZ291409B6 (hu) |
| DE (1) | DE69907675T2 (hu) |
| EA (1) | EA003332B1 (hu) |
| EE (1) | EE200000767A (hu) |
| ES (1) | ES2196824T3 (hu) |
| GB (1) | GB9813576D0 (hu) |
| GE (1) | GEP20033143B (hu) |
| HR (1) | HRP20000879A2 (hu) |
| HU (1) | HUP0102894A3 (hu) |
| ID (1) | ID27771A (hu) |
| IL (2) | IL139775A0 (hu) |
| IS (1) | IS2258B (hu) |
| MY (1) | MY124341A (hu) |
| NO (1) | NO317992B1 (hu) |
| NZ (1) | NZ508290A (hu) |
| PE (1) | PE20000710A1 (hu) |
| PL (1) | PL204650B1 (hu) |
| RS (1) | RS49746B (hu) |
| SK (1) | SK285307B6 (hu) |
| TR (1) | TR200003789T2 (hu) |
| TW (1) | TWI222449B (hu) |
| WO (1) | WO1999067245A1 (hu) |
| ZA (1) | ZA200007485B (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2345443A (en) * | 1999-01-08 | 2000-07-12 | Merck Sharp & Dohme | Use of triazolo-pyridazines for treating premenstrual syndrome |
| US20050042194A1 (en) | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| GB0111191D0 (en) * | 2001-05-08 | 2001-06-27 | Merck Sharp & Dohme | Therapeutic agents |
| KR101075812B1 (ko) | 2002-12-18 | 2011-10-25 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로서의 트리아졸로피리다진 |
| WO2006061428A2 (en) * | 2004-12-10 | 2006-06-15 | Universität Zürich | Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| US8501738B2 (en) * | 2009-06-23 | 2013-08-06 | Concert Pharmaceuticals, Inc. | Substituted triazolo-pyridazine derivatives |
| US20110082147A1 (en) * | 2009-07-24 | 2011-04-07 | Concert Pharmaceuticals, Inc. | Substituted imidazotriazines |
| US8278460B2 (en) | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
| CN102791715B (zh) | 2009-12-31 | 2016-04-27 | 卡洛斯三世国家癌症研究中心基金会 | 用作激酶抑制剂的三环化合物 |
| WO2012098387A1 (en) * | 2011-01-18 | 2012-07-26 | Centro Nacional De Investigaciones Oncológicas (Cnio) | 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors |
| US9586963B2 (en) | 2011-09-27 | 2017-03-07 | Genfit | Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists |
| MX2018009252A (es) | 2016-01-27 | 2019-01-21 | Univ Zuerich | Uso de moduladores de receptores de gabaa para el tratamiento de picor. |
| AU2019255282B2 (en) * | 2018-04-18 | 2024-08-08 | Neurocycle Therapeutics, Inc. | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |
| SI3849976T1 (sl) | 2018-09-13 | 2023-03-31 | Saniona A/S | Ligand receptorja GABA A |
| HU231223B1 (hu) | 2018-09-28 | 2022-01-28 | Richter Gedeon Nyrt. | GABAA A5 receptor modulátor hatású biciklusos vegyületek |
| WO2021191837A1 (en) | 2020-03-26 | 2021-09-30 | Richter Gedeon Nyrt. | 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69720732T2 (de) | 1996-07-25 | 2004-01-29 | Merck Sharp & Dohme | Substituierte Triazolo-Pyridazin-Derivate als Liganden von GABA-Rezeptoren |
-
1998
- 1998-06-24 GB GBGB9813576.7A patent/GB9813576D0/en not_active Ceased
-
1999
- 1999-06-15 HU HU0102894A patent/HUP0102894A3/hu unknown
- 1999-06-15 BR BR9911563-8A patent/BR9911563A/pt not_active Application Discontinuation
- 1999-06-15 CA CA002335328A patent/CA2335328C/en not_active Expired - Fee Related
- 1999-06-15 DE DE69907675T patent/DE69907675T2/de not_active Expired - Lifetime
- 1999-06-15 KR KR1020007014680A patent/KR100604108B1/ko not_active IP Right Cessation
- 1999-06-15 IL IL13977599A patent/IL139775A0/xx active IP Right Grant
- 1999-06-15 JP JP2000555898A patent/JP4749545B2/ja not_active Expired - Fee Related
- 1999-06-15 PL PL345332A patent/PL204650B1/pl not_active IP Right Cessation
- 1999-06-15 NZ NZ508290A patent/NZ508290A/en unknown
- 1999-06-15 ES ES99929508T patent/ES2196824T3/es not_active Expired - Lifetime
- 1999-06-15 AT AT99929508T patent/ATE239730T1/de not_active IP Right Cessation
- 1999-06-15 EP EP99929508A patent/EP1090004B1/en not_active Expired - Lifetime
- 1999-06-15 CN CNB998078352A patent/CN1138779C/zh not_active Expired - Fee Related
- 1999-06-15 ID IDW20002717A patent/ID27771A/id unknown
- 1999-06-15 SK SK1955-2000A patent/SK285307B6/sk not_active IP Right Cessation
- 1999-06-15 RS YUP-778/00A patent/RS49746B/sr unknown
- 1999-06-15 AU AU46301/99A patent/AU757315B2/en not_active Ceased
- 1999-06-15 GE GEAP19995726A patent/GEP20033143B/en unknown
- 1999-06-15 EE EEP200000767A patent/EE200000767A/xx unknown
- 1999-06-15 US US09/719,184 patent/US6630471B1/en not_active Expired - Lifetime
- 1999-06-15 CZ CZ20004872A patent/CZ291409B6/cs not_active IP Right Cessation
- 1999-06-15 TR TR2000/03789T patent/TR200003789T2/xx unknown
- 1999-06-15 EA EA200100071A patent/EA003332B1/ru not_active IP Right Cessation
- 1999-06-15 WO PCT/GB1999/001897 patent/WO1999067245A1/en active IP Right Grant
- 1999-06-16 MY MYPI99002465A patent/MY124341A/en unknown
- 1999-06-18 CO CO99038282A patent/CO5031239A1/es unknown
- 1999-06-22 PE PE1999000557A patent/PE20000710A1/es not_active Application Discontinuation
- 1999-06-23 AR ARP990103008A patent/AR018925A1/es active IP Right Grant
- 1999-06-28 TW TW088110866A patent/TWI222449B/zh active
-
2000
- 2000-11-20 IL IL139775A patent/IL139775A/en not_active IP Right Cessation
- 2000-11-24 IS IS5730A patent/IS2258B/is unknown
- 2000-12-14 ZA ZA200007485A patent/ZA200007485B/en unknown
- 2000-12-18 HR HR20000879A patent/HRP20000879A2/hr not_active Application Discontinuation
- 2000-12-21 NO NO20006576A patent/NO317992B1/no not_active IP Right Cessation
-
2001
- 2001-01-15 BG BG105152A patent/BG64989B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102894A2 (hu) | Helyettesített triazolopiridazin-származék, valamint ilyen vegyületet tartalmazó gyógyászati készítmények | |
| Arsenis et al. | Purification of liver flavokinase by column chromatography on flavin-cellulose compounds | |
| US4579849A (en) | N-alkylguanine acyclonucleosides as antiviral agents | |
| WO1996013512B1 (en) | L-ribofuranosyl nucleosides | |
| HK1082684A1 (en) | Use of B-D-dioxolanyl nucleosides in the manufacturing pharmaceuticals | |
| AU637015B2 (en) | Dideoxydidehydrocarbocyclic pyrimidines | |
| HUT59081A (en) | Process for producing aryl- and heteroaryl-ethylene derivatives and pharmaceutical compositions containing them | |
| Johnson et al. | 785. A partial synthesis of the vitamin B 12 coenzyme and some of its analogues | |
| FR2442848A1 (fr) | Nouvelles phenyl-6 1,2,4-triazolo(4,3-b)pyridazines substituees, leurs utilisations comme anxiolytiques et hypotenseurs et leur procede de preparation | |
| AU1428801A (en) | Novel (1,2,3)-triazolo(4,5-D)pyrimidine compounds | |
| Baker et al. | A total synthesis of pentostatin, the potent inhibitor of adenosine deaminase | |
| IE883453L (en) | Ergoline derivatives | |
| HUP9800865A2 (hu) | Kondenzált piperidinszármazékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| CA2082528A1 (en) | Antitumor substance be-13793c derivatives | |
| IE782118L (en) | Tetrazole derivatives | |
| Kato et al. | Lithiation-mediated C C silyl and stannyl migrations observed in 6-chloro-9-(β-d-ribofuranosyl) purine | |
| Gottstein et al. | Synthesis and. beta.-lactamase inhibitory properties of 2. beta.-(chloromethyl)-2. alpha.-methylpenam-3. alpha.-carboxylic acid 1, 1-dioxide | |
| EP1363637A1 (en) | Pyrimidine compounds and methods for making and using the same | |
| ES2013379A6 (es) | Procedimiento para preparar 6-sulfenamido-6, sulfinamido- y 6-sulfonamido-purinas, nucleosidos de purinas y nucleotidos de purinas antitumorales. | |
| Allen et al. | Photolysis of 5-iodopyrimidines in benzene or heteroarenes; a convenient route to 5-phenyl-and 5-heteroaryl-pyrimidines | |
| JPS57146798A (en) | Hexosyl nucleoside derivative | |
| Koszalka et al. | 6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus | |
| ATE109154T1 (de) | 2'-methylidenpyrimidin-nukleoside, ihre verwendung und verfahren zu ihrer herstellung. | |
| JPS54151987A (en) | Preparation of 3',5'-disubstituted-2'-deoxy-beta-uridines and 2'-deoxy-beta-urdines | |
| IE44708L (en) | Esters of hydroxy alkoxyalkyl purines |